[Abstract Only] Randomized Trial: Teprotumumab for the Treatment of Active Thyroid Eye Disease
24 Jan, 2020 | 08:07h | UTCTeprotumumab for the Treatment of Active Thyroid Eye Disease – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Teprotumumab bests placebo for active thyroid eye disease – MedicalXpress (free)